News

Impatient with Meta’s slow progress in A.I., Zuckerberg in recent months has personally spearheaded an aggressive recruiting ...
Google DeepMind has officially launched Gemma 3n, the latest version of its lightweight generative AI model designed ...
Google DeepMind has officially launched Gemma 3n, the latest version of its lightweight generative AI model designed ...
Kate Middleton’s Gesture at Surprise Engagement Is Right Out of Princess Diana’s Playbook Dumb Things In The Big Bang Theory ...
DeepMind’s latest breakthrough is open-source and already smashing records in video tracking. Terrifying Timelapse Shows ...
A public feud over model originality threatens China’s collaborative AI front, with Huawei denying whistleblower claims of ...
Out to make a bigger difference, Alphabet’s Isomorphic Labs is exploring a much more useful application of AI. The Google ...
The decision to end the service was ultimately made by the US Department of Defense (DoD) and affects data collected by the ...
Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.
Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...
Isomorphic Labs advances towards human clinical trials for AI-designed drugs, marking a pivotal moment in pharmaceutical ...
Computers can help ensure that mathematical proofs are correct, but translating traditional maths into a machine-readable ...